Black Maple Capital Management’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Black Maple Capital Management's AMYT Position: Q2 2023 in Review
Black Maple Capital Management sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 545,693 shares — an estimated $7.96M sold.
Black Maple Capital Management first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $7.96M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.
- Black Maple Capital Management reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
- Black Maple Capital Management sold 545,693 Amryt Pharma shares in Q2 2023, an estimated $7.96M.
- Black Maple Capital Management first reported a position in Amryt Pharma in Q1 2023 and held it in 1 quarter.
- Black Maple Capital Management's Amryt Pharma position peaked at $7.96M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.
Based on Black Maple Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.